Outlook Therapeutics's total assets for Q2 2026 were $21.89T, an increase of 120033439.90% from the previous quarter. OTLK total liabilities were $50.89T for the fiscal quarter, a 89608870.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.